Tkaczyk, C., Semenova, E., Shi, Y. Y., Rosenthal, K., Oganesyan, V., Warrener, P., . . . Sellman, B. R. (2018). Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity In Vitro and Staphylococcus aureus Fitness in Infection Models. Antimicrob Agents Chemother.
Dyfyniad Arddull ChicagoTkaczyk, C., E. Semenova, Y. Y. Shi, K. Rosenthal, V. Oganesyan, P. Warrener, C. K. Stover, and B. R. Sellman. "Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity In Vitro and Staphylococcus Aureus Fitness in Infection Models." Antimicrob Agents Chemother 2018.
Dyfyniad MLATkaczyk, C., et al. "Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity In Vitro and Staphylococcus Aureus Fitness in Infection Models." Antimicrob Agents Chemother 2018.